Tiziana Life Sciences has shared positive three-month neuroimaging scores in non-active secondary progressive multiple sclerosis (na-SPMS) patients receiving intranasal foralumab. Affecting ...

The World Health Organization (WHO) has prequalified a new inactivated and simplified oral vaccine for cholera, Euvichol-S, ...

Incyte has entered into a $750m definitive agreement to acquire Escient Pharmaceuticals and its pipeline of small molecule ...

Fox&Cat has relaunched today with its new people-first, senior consultant operating model and bespoke planning framework, ...

Cerevel Therapeutics has announced positive phase 3 results for tavapadon as a once-daily treatment for patients living with ...

UCB’s Bimzelx (bimekizumab) has been approved by the European Commission (EC) to treat active moderate-to-severe hidradenitis ...

Takeda has announced that its subcutaneous (SC) Entyvio (vedolizumab) has been approved by the US Food and Drug ...

AstraZeneca’s (AZ) Voydeya (danicopan) has been approved by the European Commission (EC) as an add-on therapy for adults with ...

Regeneron Pharmaceuticals and Mammoth Biosciences have announced a collaboration aimed at developing CRISPR-based gene ...

Johnson & Johnson’s (J&J) Rybrevant (amivantamab) in combination with chemotherapy, has been recommended by the European ...

If you’ve worked in pharma marketing, you’ll know how hard it can be of late. You’ll spend a load of budget on what looks and ...

Afon Technology has been presented with Junkosha’s Technology Innovator of the Year Award, along with a $25,000 prize, for ...